Items where Author is "Sharrack, B."

CARTER, Anouska, DALEY, A., HUMPHREYS, L., SNOWDON, Nicky, WOODROOFE, Nicola, PETTY, J., ROALFE, A., TOSH, J., SHARRACK, B. and SAXTON, J. (2014). Pragmatic intervention for increasing self-directed exercise behaviour and improving important health outcomes in people with multiple sclerosis : a randomised controlled trial. Multiple Sclerosis, 20 (8), 1112-1122.

CARTER, Anouska, HUMPHREYS, Liam and SHARRACK, B. (2017). Exercise in the treatment of multiple sclerosis. In: WATSON, Ronald Ross and KILLGORE, William D. S., (eds.) Nutrition and lifestyle in neurological autoimmune diseases. Multiple sclerosis. London, Academic Press, 179-187.

TOSH, J., DIXON, S., CARTER, Anouska, DALEY, A., PETTY, J., ROALFE, A., SHARRACK, B. and SAXTON, J. M. (2014). Cost effectiveness of a pragmatic exercise intervention (EXIMS) for people with multiple sclerosis : economic evaluation of a randomised controlled trial. Multiple Sclerosis, 20 (8), 1123-1130.

SAXTON, John, CARTER, Anouska, DALEY, A.J., SNOWDON, Nicky, WOODROOFE, Nicola, PETTY, J., ROALFE, A., TOSH, J. and SHARRACK, B. (2013). Pragmatic exercise intervention for people with multiple sclerosis (ExIMS Trial) : study protocol for a randomised controlled trial. Contemporary Clinical Trials, 34 (2), 205-211.

SAXTON, J.M., CARTER, Anouska, DALEY, A.J., SNOWDON, Nicky, WOODROOFE, M.N., PETTY, J., ROALFE, A., TOSH, J. and SHARRACK, B. (2013). Pragmatic exercise intervention for people with multiple sclerosis (ExIMS Trial): Study protocol for a randomised controlled trial. Contemporary Clinical Trials, 34 (2), 205-211.

WALLER, R., WOODROOFE, M. Nicola, FRANCESE, Simona, HEATH, P.R., WHARTON, S.B., INCE, P.G., SHARRACK, B. and SIMPSON, J.E. (2012). Isolation of enriched glial populations from post-mortem human CNS material by immuno-laser capture microdissection. Journal of Neuroscience Methods, 208 (2), 108-113.

DHUNGANA, S., WATERS, P., ISMAIL, A., WOODROOFE, N., VINCENT, A. and SHARRACK, B. (2010). Absence of aquaporin-4 antibodies in patients with idiopathic intracranial hypertension. Journal of Neurology, 257 (7), 1211-1212.

DHUNGANA, S., SHARRACK, B. and WOODROOFE, N. (2010). Idiopathic intracranial hypertension. Acta neurologica Scandinavica, 121 (2), 71-82.

HURST, L. A., BUNNING, R. A. D., COURAUD, P.-O., ROMERO, I. A., WEKSLER, B. B., SHARRACK, B. and WOODROOFE, M. N. (2009). Expression of ADAM-17, TIMP-3 and fractalkine in the human adult brain endothelial cell line, hCMEC/D3, following pro-inflammatory cytokine treatment. Journal of neuroimmunology, 210 (1-2), 108-112.

DHUNGANA, S., SHARRACK, B. and WOODROOFE, N. (2009). Cytokines and chemokines in idiopathic intracranial hypertension. Headache: the journal of head and face pain, 49 (2), 282-285.

DHUNGANA, S., SHARRACK, B. and WOODROOFE, N. (2009). IL-1β, TNF and IP-10 in the cerebrospinal fluid and serum are not altered in patients with idiopathic intracranial hypertension compared to controls. Clinical endocrinology, 71 (6), p. 896.

HADJIVASSILIOU, M., BOSCOLO, S., TONGIORGI, E., GRÜNEWALD, R. A., SHARRACK, B., SANDERS, D. S., WOODROOFE, N. and DAVIES-JONES, G. A. B. (2008). Cerebellar ataxia as a possible organ-specific autoimmune disease. Movement disorders, 23 (10), 1370-1377.

HADDOCK, G., CROSS, A. K., ALLAN, S., SHARRACK, B., CALLAGHAN, J. T., BUNNING, R. A., BUTTLE, D. J. and WOODROOFE, M. N. (2007). Brevican and phosphacan expression and localization following transient middle cerebral artery occlusion in the rat. Biochemical Society Transactions, 35 (4), p. 692.